Ann: Quarterly Cashflow Report, page-4

First 4 Last

Share
Profile

Follow
longtermlegs

3,237 Posts.

29/10/15

21:51

Post #: 16287035
Share

Originally posted by Stoops ↑

ltl,

For the readers of this post I will provide a little recent history.

I recently posted on the NTU forum and ltl critised me for doing so because I was a non-holder of NTU. NTU is another rare earth explorer attempting to get into production. The magor difference between CUX and NTU is that CUX has a greater mix of rare eaths whereas NTU is dependent of the large % of Dy in its mix.

Suffice to say ltl is an avid supporter of NTU and any perceived challenge to NTU will be met with negative response by ltl and an attack on the Company which the perceived challenger holds an interest in. At best, IMHO, the above post is an example of ltl's hypocrisy. At worst it is an example of ltl trying to down ramp any company that could compete with his beloved NTU. I will let you chose what ltl's motives are.

I would suggest that by what ltl said in his post and his recommendation to sell CUX, is that he doesn't understand the benefits of the recent actions of the Management of CUX, the negative affects of the relationship with PUC and the potential benefits of the new partners in Charlie Creek.

I would recommend that holders of CUX do their own research and take any advice or comment, provided by ltl on CUX with a large grain of salt.

Cheers

Stoops

Expand

once again Sloops, I ask:- do you know how to read a cashflow report

It's not a pretty picture

Looks to be on life support to me

CUX Price at posting: 0.8¢ Sentiment: Sell Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Chaos reigns markets – so let's take stock of where we're at ahead of December

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 12 more messages in this thread...

First 4 Last

Add CUX (ASX) to my watchlist

Ann: Quarterly Cashflow Report, page-4

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Chaos reigns markets – so let's take stock of where we're at ahead of December

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game